← Back to Search

Speeko for Elderspeak for Dementia

N/A
Waitlist Available
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up four app recording sessions per nursing home, through study completion, 1 year.
Awards & highlights
No Placebo-Only Group

Summary

This trial tests an app that helps nursing home staff improve communication with residents with dementia. The app listens to conversations and aims to reduce negative behaviors in residents and make care easier for staff.

Eligible Conditions
  • Dementia
  • Staff Attitudes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~four app recording sessions per nursing home, through study completion, 1 year.
This trial's timeline: 3 weeks for screening, Varies for treatment, and four app recording sessions per nursing home, through study completion, 1 year. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in elderspeak measured by the number of diminutives detected in participant's recorded speech.
Secondary study objectives
Acceptability as measured by System Usability Scale.
Evaluate the app cost by measuring wages per hour by NH role and costs associated with the Speeko for Elderspeak application.

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TreatmentExperimental Treatment1 Intervention
The treatment NHs will received immediate feedback from the Speeko App after each recording sessions
Group II: ControlActive Control1 Intervention
The Control NHs will not receive app feedback until all recording sessions are complete.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Speeko for Elderspeak
2021
N/A
~30

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
510 Previous Clinical Trials
176,870 Total Patients Enrolled
11 Trials studying Dementia
3,974 Patients Enrolled for Dementia
National Institute on Aging (NIA)NIH
1,788 Previous Clinical Trials
28,184,517 Total Patients Enrolled
292 Trials studying Dementia
23,634,483 Patients Enrolled for Dementia
~6 spots leftby Nov 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top